Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01CBK
|
|||
| Former ID |
DIB009103
|
|||
| Drug Name |
OSE2101
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 3 | [1] | |
| Non-small-cell lung cancer [ICD-11: 2C25.Y] | Phase 3 | [2] | ||
| Company |
Ose pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017699) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.